Follow The Filings

MET MetLife

Financials, filed as METLIFE INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 0.0%
  • $15K

Who owns this now

Largest portfolio weights among holders, up to 0.0% (Kentucky Trust Co., Kentucky Trust). Not free-float ownership.

  1. Kentucky Trust Co. 0.01%

Who owns MET

Sorted by value, long equity only, as of 2026 Q3.

History
Kentucky Trust Co., Kentucky Trust 0.01% Hold 154 $15K History

1 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by MET's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MET insider trades
  • None no insider bought on the open market
  • $1.7M sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Marlene Debel EVP & Chief Risk Officer
    Sale
    $1.7M 21,312 shares at $81.59 12% of stake
    Traded Jun 1 Filed Jun 3
    ↗

Also filed in the last 12 months, not counted as buying or selling: 92 stock grants, 18 share withholdings for taxes, and 2 option exercises.

Congress

5 members of Congress traded MET in the last three years: 1 buy and 4 sales. 6 members listed it in 2025 annual reports.

All Congress trades
  1. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  2. Gilbert Ray Cisneros, Jr. D-CA-31 Partial sale $1K–$15K Aug 6, 2025 filed Sep 12, 2025
  3. Ritchie Torres D-NY-15 Sell $1K–$15K Jul 11, 2025 filed Aug 20, 2025
  4. Sheldon Whitehouse D-RISpouse Sell $1K–$15K Nov 19, 2024 filed Dec 5, 2024
  5. Thomas R. Carper D-DESpouse Partial sale $1K–$15K Jan 17, 2024 filed Feb 2, 2024

SEC filings

Recent issuer filings from EDGAR, 7 shown.

Filed Form Detail Links
8-K 7.01 Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,8.01,9.01 Filing Doc
8-K 7.01 Filing Doc
8-K 5.07 Filing Doc

Source: SEC EDGAR submissions, updated 12 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $2.23B $2.24B $2.44B
Net income $1.58B $4.43B $3.38B
Net margin * 70.8% 197.1% 138.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total assets $687.58B $677.46B $745.17B
Total equity $30.02B $27.44B $28.4B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $13.72B $14.6B $17.09B
Cash from investing -$10.25B -$11.49B -$15.61B
Cash from financing -$2.94B -$3.13B $0.163B
Net change in cash $0.444B -$0.571B $1.96B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.